Combined Modality Treatment of Resectable and Borderline Resectable Pancreas Cancer: Expert Consensus Statement

被引:217
作者
Abrams, Ross A. [1 ]
Lowy, Andrew M. [2 ]
O'Reilly, Eileen M. [3 ]
Wolff, Robert A. [4 ]
Picozzi, Vincent J. [5 ]
Pisters, Peter W. T. [6 ]
机构
[1] Rush Univ, Med Ctr, Dept Radiat Oncol, Chicago, IL 60612 USA
[2] Univ Calif San Diego, Div Surg Oncol, San Diego, CA 92103 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Med, Gastrointestinal Oncol Serv, New York, NY 10021 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
[5] Virginia Mason Med Ctr, Pancreaticobiliary Canc Digest Dis Inst, Seattle, WA 98101 USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
关键词
RANDOMIZED CONTROLLED-TRIAL; GEMCITABINE-BASED CHEMORADIATION; CURATIVE RESECTION; PREOPERATIVE CHEMORADIATION; ADJUVANT CHEMOTHERAPY; RADIATION-THERAPY; ADENOCARCINOMA; PANCREATICODUODENECTOMY; CARCINOMA; RADIOTHERAPY;
D O I
10.1245/s10434-009-0413-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1751 / 1756
页数:6
相关论文
共 30 条
[1]   RTOG 9704 - Radiotherapy quality assurance (QA) review and survival [J].
Abrams, R. A. ;
Winter, K. A. ;
Regine, W. F. ;
Safran, H. ;
Hoffman, J. P. ;
Konski, A. A. ;
Benson, A. B. ;
Macdonald, J. S. ;
Rich, T. A. ;
Willett, C. G. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03) :S22-S22
[2]   ADJUVANT THERAPY WITH CHEMOTHERAPY AND RADIATION-THERAPY IN THE MANAGEMENT OF CARCINOMA OF THE PANCREATIC HEAD [J].
ADAMS, RA ;
GROCHOW, LB .
SURGICAL CLINICS OF NORTH AMERICA, 1995, 75 (05) :925-+
[3]  
[Anonymous], NCCN UPD PANCR AD GU
[4]   ADJUVANT COMBINATION CHEMOTHERAPY (AMF) FOLLOWING RADICAL RESECTION OF CARCINOMA OF THE PANCREAS AND PAPILLA OF VATER - RESULTS OF A CONTROLLED, PROSPECTIVE, RANDOMIZED MULTICENTER STUDY [J].
BAKKEVOLD, KE ;
ARNESJO, B ;
DAHL, O ;
KAMBESTAD, B .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (05) :698-703
[5]  
BERGER A, 2007, J CLIN ONCOL S, V207, P4522
[6]   Extended lymphadenectomy and vein resection for pancreatic head cancer -: Outcomes and implications for therapy [J].
Capussotti, L ;
Massucco, P ;
Ribero, D ;
Viganò, L ;
Muratore, A ;
Calgaro, M .
ARCHIVES OF SURGERY, 2003, 138 (12) :1316-1322
[7]   Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: The Mayo Clinic experience (1975-2005) [J].
Corsini, Michele M. ;
Miller, Robert C. ;
Haddock, Michael G. ;
Donohue, John H. ;
Farnell, Michael B. ;
Nagorney, David M. ;
Jatoi, Aminah ;
McWilliams, Robert R. ;
Kim, George P. ;
Bhatia, Sumita ;
Iott, Matthew J. ;
Gunderson, Leonard L. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) :3511-3516
[8]  
EVANS DB, 1992, ARCH SURG-CHICAGO, V127, P1335
[9]   Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head [J].
Evans, Douglas B. ;
Varadhachary, Gauri R. ;
Crane, Christopher H. ;
Sun, Charlotte C. ;
Lee, Jeffrey E. ;
Pisters, Peter W. T. ;
Vauthey, Jean-Nicolas ;
Wang, Huamin ;
Cleary, Karen R. ;
Staerkel, Gregg A. ;
Charnsangavej, Chusilp ;
Lano, Elizabeth A. ;
Ho, Linus ;
Lenzi, Renato ;
Abbruzzese, James L. ;
Wolff, Robert A. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) :3496-3502
[10]  
GRIFFIN JF, 1990, CANCER, V66, P56, DOI 10.1002/1097-0142(19900701)66:1<56::AID-CNCR2820660112>3.0.CO